Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

0QAH

Merck & (0QAH)

Merck & Co Inc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:0QAH
일자시간출처헤드라인심볼기업
2024/04/2520:13Alliance NewsAlliance NewsMerck & Co raises annual outlook thanks to first quarter boostLSE:0QAHMerck & Co Inc
2024/03/1600:23Alliance NewsAlliance NewsIN BRIEF: Merck hails positive data on cervical cancer drug, KeytrudaLSE:0QAHMerck & Co Inc
2024/02/2106:15Alliance NewsAlliance NewsMerck and Astellas drugs get priority review in US and JapanLSE:0QAHMerck & Co Inc
2024/02/0121:57Alliance NewsAlliance NewsTOP NEWS: Merck books 2023 growth despite gefapixant rejection hitLSE:0QAHMerck & Co Inc
2024/01/1920:29Alliance NewsAlliance NewsIN BRIEF: Arix Bioscience eyes USD19 million return from Harpoon saleLSE:0QAHMerck & Co Inc
2024/01/0823:20Alliance NewsAlliance NewsMerck to buy Harpoon Therapeutics for about USD680 millionLSE:0QAHMerck & Co Inc
2023/12/1820:04Alliance NewsAlliance NewsAstellas, Merck, Pfizer celebrate US approval for Keytruda plus PadcevLSE:0QAHMerck & Co Inc
2023/12/1517:41Alliance NewsAlliance NewsMerck gets US FDA nod for Welireg, as trial with Moderna bears fruitLSE:0QAHMerck & Co Inc
2023/12/1202:56Alliance NewsAlliance NewsMerck reports mixed updates for cancer treatment, KeytrudaLSE:0QAHMerck & Co Inc
2023/10/2620:17Alliance NewsAlliance NewsTOP NEWS: Merck hails Daiichi Sankyo partnership but will take chargeLSE:0QAHMerck & Co Inc
2023/10/2014:06Alliance NewsAlliance NewsTOP NEWS: Daiichi Sankyo soars on USD22 billion Merck cancer drug dealLSE:0QAHMerck & Co Inc
2023/10/0401:00Alliance NewsAlliance NewsDrugmakers agree to US government price talks amid pushbackLSE:0QAHMerck & Co Inc
2023/08/2500:24Alliance NewsAlliance NewsUPDATE: AstraZeneca, Merck & Co say Lynparza approved in JapanLSE:0QAHMerck & Co Inc
2023/08/0120:49Alliance NewsAlliance NewsMerck & Co second quarter revenue up; profit falls acquisition costsLSE:0QAHMerck & Co Inc
2023/06/1621:09Alliance NewsAlliance NewsMerck says latest trial data shows Keytruda meets survival endpointLSE:0QAHMerck & Co Inc
2023/06/0121:44Alliance NewsAlliance NewsMerck and Astra's Lynparza prostate cancer treatment gets US approvalLSE:0QAHMerck & Co Inc
2023/05/0120:35Alliance NewsAlliance NewsAstraZeneca "disappointed" with US ODAC's guidance on LynparzaLSE:0QAHMerck & Co Inc
2023/04/2720:49Alliance NewsAlliance NewsMerck & Co beats on first-quarter revenue and hails "advancements"LSE:0QAHMerck & Co Inc
2023/03/1021:31Alliance NewsAlliance NewsMerck's Keytruda combination sees positive results in cancer trialLSE:0QAHMerck & Co Inc
2023/03/0302:20Alliance NewsAlliance NewsUS FDA to discuss AstraZeneca and Merck's Lynparza cancer drug comboLSE:0QAHMerck & Co Inc
2023/02/2421:48Alliance NewsAlliance NewsIN BRIEF: EU refuses marketing recommendation for Merck's LagevrioLSE:0QAHMerck & Co Inc
2023/02/0222:08Alliance NewsAlliance NewsTOP NEWS: Merck & Co annual net profit up but drops in fourth-quarterLSE:0QAHMerck & Co Inc
2023/01/3101:35Alliance NewsAlliance NewsDaiichi begins Tropion-Lung07 phase 3 trial for lung cancer treatmentLSE:0QAHMerck & Co Inc
2022/12/2118:16Alliance NewsAlliance NewsAstraZeneca wins two new approvals in EU for cancer drugsLSE:0QAHMerck & Co Inc
2022/12/2103:09Alliance NewsAlliance NewsFDA accepts Astellas, Seagen and Merck's combo for priority reviewLSE:0QAHMerck & Co Inc
2022/12/1517:37Alliance NewsAlliance NewsAstraZeneca and Merck receive US FDA extension for Lynparza reviewLSE:0QAHMerck & Co Inc
2022/11/2302:18Alliance NewsAlliance NewsIN BRIEF: Merck's Keytruda sees positive topline results in trialLSE:0QAHMerck & Co Inc
2022/11/2121:53Alliance NewsAlliance NewsMerck buys biopharmaceutical firm Imago BioSciences for USD1.4 billionLSE:0QAHMerck & Co Inc
2022/10/2722:29Alliance NewsAlliance NewsTOP NEWS: Merck & Co 3rd-quarter sales up; profit slips as costs riseLSE:0QAHMerck & Co Inc
2022/09/0922:31Alliance NewsAlliance NewsAstraZeneca, Merck's Lynparza shows survival benefit in ovarian cancerLSE:0QAHMerck & Co Inc
 검색 관련기사 보기:LSE:0QAH